Related Experiment Video
Updated: Nov 12, 2025
07:55
Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer
Published on: January 17, 2025
1.3K
TOX as a potential target for immunotherapy in lymphocytic malignancies
Chaofeng Liang1,2, Shuxin Huang1, Yujie Zhao1
1Key Laboratory for Regenerative Medicine of Ministry of Education; Institute of Hematology, School of Medicine, Jinan University, Guangzhou, 510632, China.
Biomarker Research
|March 21, 2021
Summary
Thymocyte selection-associated HMG BOX (TOX) protein promotes T cell exhaustion and tumor growth. This review explores TOX
Area of Science:
- Immunology
- Molecular Biology
- Oncology
Background:
- TOX is a transcriptional factor with a conserved HMG-box domain.
- Emerging evidence links TOX to tumor progression and T cell exhaustion.
Purpose of the Study:
- To review the biological functions of TOX.
- To examine TOX's role in lymphocytic malignancies.
- To discuss TOX as a potential biomarker and therapeutic target in hematological malignancies.
Main Methods:
- Literature review of studies on TOX.
- Analysis of TOX's involvement in T cell exhaustion.
- Evaluation of TOX's role in hematological cancers.
Main Results:
- TOX plays a critical role in T cell exhaustion.
- TOX contributes to the development and maintenance of tumors.
- TOX is implicated in various lymphocytic malignancies.
Conclusions:
- TOX is a key regulator of T cell function and cancer.
- Targeting TOX may offer a novel immunotherapy strategy for hematological malignancies.
- TOX serves as a potential immune biomarker for predicting treatment response.
Related Concept Videos
01:27Tumor Immunotherapy
820
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
820
02:57Targeted Cancer Therapies
8.1K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.1K
01:30Cancer Vaccines
610
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
610
01:27Cytotoxic T Cells-mediated Immune Response
5.8K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
5.8K